4//SEC Filing
Harper Sean E 4
Accession 0001127602-18-015838
CIK 0000318154other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 7:07 PM ET
Size
8.0 KB
Accession
0001127602-18-015838
Insider Transaction Report
Form 4
AMGEN INCAMGN
Harper Sean E
EVP, Research & Development
Transactions
- Award
Nqso (Right to Buy)
2018-04-27+34,702→ 34,702 totalExercise: $177.46From: 2020-04-27Exp: 2028-04-27→ Common Stock (34,702 underlying) - Award
Common Stock
2018-04-27+4,508→ 61,296 total
Footnotes (4)
- [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 4/27/2020, 4/27/2021 and 4/27/2022, respectively.
- [F2]These shares include the following RSUs granted under the Company's equity plans: 1,340 RSUs which vest in one installment on 1/30/2019; 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020; and 4,551 RSUs which vest in installments of 1,501 on 5/1/2019, 1,502 on 5/1/2029 and 1,548 on 5/1/2021. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- [F3]These shares include 477 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
- [F4]These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 4/27/2020, 4/27/2021 and 4/27/2022, respectively.
Documents
Issuer
AMGEN INC
CIK 0000318154
Entity typeother
Related Parties
1- filerCIK 0001541946
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 7:07 PM ET
- Size
- 8.0 KB